Interferon γ (IFNγ) gene transfer of an EMT6 tumor that is poorly responsive to IFNγ stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s002620050258PMCID PMC11037720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.

  1995cited by this paper
• Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).

  1995cited by this paper
• Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

  1994influential reference
• Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes

  1994influential reference
• Using mismatched primer-template pairs in touchdown PCR.

  1994cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• Tumor cells expressing major histocompatibility complex class II and B7 activation molecules stimulate potent tumor-specific immunity.

  1993cited by this paper
• The biochemistry and cell biology of antigen processing and presentation.

  1993cited by this paper
• gamma-Interferon plays a key role in T-cell-induced tumor regression.

  1993cited by this paper
• Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.

  1993influential reference
• Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

  1993influential reference
• Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.

  1992cited by this paper
• A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

  1992influential reference
• Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.

  1992cited by this paper
• Invariant chain alters the malignant phenotype of MHC class II+ tumor cells.

  1992cited by this paper
• Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras

  1991cited by this paper
• Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

  1991cited by this paper
• Rejection of mouse sarcoma cells after transfection of MHC class II genes.

  1990cited by this paper
• Direct evidence for an intracellular role for IFN-gamma. Microinjection of human IFN-gamma induces Ia expression on murine macrophages.

  1990cited by this paper
• Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

  1990influential reference
• Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

  1989influential reference
• Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.

  1988cited by this paper
• The influence of major histocompatibility complex class I antigens on tumor growth and metastasis.

  1987cited by this paper
• Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells.

  1987cited by this paper
• Histocompatibility antigens on murine tumors.

  1985cited by this paper

• Using major histocompatibility complex (MHC) II expression to predict antitumor response to CD4 + lymphocyte depletion

  2025cites this paper
• MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer

  2025cites this paper
• Amateur antigen‐presenting cells in the tumor microenvironment

  2021cites this paper
• Biological Consequences of MHC-II Expression by Tumor Cells in Cancer

  2018cites this paper
• CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.

  2014cites this paper
• Novel Amplifier Expression Vectors Producing Higher Levels of IL-2 Led to Slower Tumor Growth and Longer Survival In Vivo

  2005cites this paper
• Persistence of MHC DR Nonexpression on Swine Cells by Introduction of a Mutated MHC Class II Transactivator Gene: A Comparison with the Effect Induced by Antisense RNA

  2004cites this paper
• DEVELOPMENT OF IMPROVED EXPRESSION VECTORS AND THEIR APPLICATIONS IN CANCER GENE THERAPY

  2003cites this paper
• Bacterial infection induces expression of functional MHC class II molecules in murine and human osteoblasts.

  2003cites this paper
• Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo

  2002cites this paper
• T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance

  2001cites this paper
• The bare lymphocyte syndrome and the regulation of MHC expression.

  2001cites this paper
• Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression

  2000cites this paper
• Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity

  2000cites this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cites this paper
• Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression

  2000cites this paper
• Significance and Regulation of the Expression of MHC Class II Molecules on Autoimmune and Neoplastic Thyroid Cells

  2000cites this paper
• Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

  1999cites this paper
• Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF‐β, IL‐4, IL‐13 and IL‐10

  1999cites this paper
• Immune Modulation as Cancer Treatment Using Gene Therapy

  1999cites this paper
• Phase I Trial of Interferon gamma Retroviral Vector Administered Intratumorally with Multiple Courses in Patients with Metastatic Melanoma

  1999cites this paper
• Isolation of a B-cell-specific promoter for the human class II transactivator

  1997cites this paper
• Effect of antisense TGF-beta transgene expression on the immunogenicity of EMT6 murine mammary carcinoma cells

  1997cites this paper